Vaccines

Public health experts express concern over the CDC's revised vaccine-autism webpage, warning it may fuel mistrust and confusion about vaccine safety.

The CDC's recent update on vaccines and autism sparks confusion, raising concerns about public trust and the implications for vaccine safety.

mRNA COVID-19 vaccines enhance immune responses, improving cancer treatment outcomes with immune checkpoint inhibitors and offering hope for hard-to-treat tumors.

A recent JAMA Pediatrics study revealed the enduring effectiveness of the HPV vaccine, highlighting its role in reducing cancer risk among young women.

A real-world analysis shows Shingrix effectively prevents shingles in adults over the age of 65, including immunocompromised people. Two doses provide better protection than one.

A study revealed that the 2024-2025 COVID-19 vaccine significantly reduces emergency visits, hospitalizations and deaths among U.S. veterans.

The CDC updates vaccine schedules, emphasizing personalized decision-making for COVID-19 shots and recommending standalone chickenpox vaccines for toddlers.

The Advisory Committee on Immunization Practices pulled back its recommendation concerning a shot that combines the measles, mumps and rubella vaccine with one for varicella. A vote on the hepatitis B vaccine at birth was postponed until tomorrow.

ACIP's upcoming meeting addresses vital vaccine updates, including COVID-19 and MMRV, while introducing new members to enhance public health transparency.

Parents express mixed feelings about COVID-19 vaccines, revealing a significant divide in trust and safety perceptions, according to a KFF survey analysis.

Jennifer Walsh of George Washington University’s School of Nursing warned that limiting COVID-19 vaccine approvals to older adults and high-risk groups could heighten disparities, reduce access and leave vulnerable populations at greater risk of infection and severe outcomes.

Parents are facing mixed messages on back-to-school vaccines, with David Dodd of GeoVax urging families to prioritize required school shots first, then flu and RSV, while weighing COVID-19 decisions with their pediatrician amid conflicting federal and pediatric guidance.

COVID-19 reveals significant political polarization in public health, impacting vaccine attitudes and infection concerns among Democrats and Republicans.

Experts criticize the FDA's narrow COVID-19 vaccine approval, warning it limits access and undermines public health amid rising hospitalization rates.

The FDA suspends Ixchiq, the first approved chikungunya vaccine, over safety concerns, impacting its availability in the U.S. market.

The 2023-2024 COVID-19 vaccine proves cost-effective, especially for older adults, significantly reducing illness and hospitalizations across all age groups.

HHS reinstates the Task Force on Safer Childhood Vaccines to enhance vaccine safety and oversight amid concerns over recent ACIP changes.

Recent research confirms that aluminum in childhood vaccines does not increase the risk of autoimmune, allergic or neurodevelopmental disorders.

A new report by Commonwealth Fund ranks all 50 states and the District of Columbia across 50 indicators covering access, quality, outcomes and equity from data collected up to 2023.

The nominee for HHS secretary hedged this answers to questions about vaccine safety and efficacy at his second confirmation hearing today.

The development of avian influenza vaccines is the main priority amid rising cases in the United States.

The Biotechnology Innovation Organization has some suggestions, including "platform designation" by FDA and changes at the CDC.

A study found that the mRNA-1647 vaccine candidate developed by Moderna elicited strong immune responses. The mRNA vaccine is now in phase 3 clinical trials to determine its effectiveness in protecting against CMV.

A study published in The Lancet revealed the efficacy of a single-dose typhoid conjugate vaccine. The four-year, phase 3 trial assessed the vaccine's effectiveness in preventing typhoid fever in Malawian children.